[ 01 ]
[ 02 ]
The equity research process stands out for its depth, quality, and attention to detail. The goal is to develop an understanding of each holding that stays one step ahead of long-term consensus.
[ 03 ]
The price of admission for attractive long-term returns is to endure volatility. The fund remains fully invested in nearly all market environments and avoids common behavioral pitfalls such as market timing, hedging, or reactive trading.
[ 04 ]
Fund advisor Timo Buss has invested nearly 100% of his liquid assets in the fund and increases this commitment each year. Other investors include family offices, fund-of-funds, and high-net-worth individuals.
[ 05 ]
Disclaimer:The information provided above by Covesto Asset Management GmbH does not constitute an offer or a recommendation to hold, purchase, or sell any financial instrument. The content is solely for non-binding informational purposes (marketing). For detailed information on opportunities and risks, please consult your bank or investment advisor, as well as the sales prospectus and the Key Information Document (PRIIP-KID).
Risk Notice: Investments in securities are generally subject to risks, in particular the risk of a total loss of the capital invested. The value of an investment may rise or fall. Investors may not recover the full amount they invested. The information contained in this publication is non-binding, and Covesto Asset Management GmbH does not assume any liability for its completeness, accuracy, or timeliness. There is no obligation to update or amend the contents to reflect future developments.
01.01.2020
11.02.2020
DE000A2PR0E7
A2PR0E
Covesto Patient Capital I
High
UCITS
>51%
Established Companies
Global
Top-5: approx. 40%, Top-17: approx. 80%
None
0.0% (subject to agreement)
1.34% (thereof: 1.00% advisor fee)
EN
31.07.
HANSAINVEST
UBS
As of December 2024
Disclaimer: The linked content is provided solely for non-binding informational purposes (marketing). It does not constitute an offer or a recommendation to hold, acquire, or sell financial instruments and does not qualify as investment research.
Target Group Notice: The linked content is intended exclusively for professional or semi-professional investors as defined in Section 67 (2) and (3) of the German Securities Trading Act (WpHG), who are resident or habitually located in Germany. By accessing this information, you confirm that you belong to this category of investors.
If you would like to receive the annual investor letter, exclusive business model breakdowns, and updates about the fund, please enter your contact details in the form below. The newsletter is sent approximately 3 to 4 times per year.*
If you would like to receive the annual investor letter, exclusive business model breakdowns, and updates about the fund, please enter your contact details in the form below. The newsletter is sent approximately 3 to 4 times per year.*
*By subscribing, you confirm that you have read the privacy policy and that you are a professional or semi-professional investor within the meaning of Section 67 (2) and (3) of the German Securities Trading Act (WpHG), with residence or habitual abode in Germany. Your data will be used exclusively for sending the newsletter and will not be shared with third parties – except for our service provider Mailchimp, a U.S.-based marketing automation platform.
By submitting the form, you consent to the processing of your data in accordance with Mailchimp’s privacy policy and terms. This may involve the transfer of your data to a third country (USA). Mailchimp is committed to ensuring an adequate level of data protection based on the EU Standard Contractual Clauses (SCCs).
You may withdraw your consent at any time – via the unsubscribe link in each email or by contacting us at contact@covesto-am.com.
